GeneReach Biotechnology Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 235.73 million compared to TWD 233.24 million a year ago.

Revenue was TWD 235.68 million compared to TWD 232.55 million a year ago. Net income was TWD 99.82 million compared to TWD 93.05 million a year ago. Basic earnings per share from continuing operations was TWD 2.1727 compared to TWD 2.0273 a year ago.

Diluted earnings per share from continuing operations was TWD 2.0909 compared to TWD 2.0182 a year ago.